Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
AOD-9604 was advanced through Phase I and Phase II clinical trials by Metabolic Pharmaceuticals between roughly 2003 and 2007 enrolling approximately 900 participants in total
Methylene Blue IV therapy represents a new era in neuroprotection and enhancement, offering hope and advanced treatment options for a range of neurological conditions
Its a B12 shot, double dose lipotropic MIC, and topped with taurine to aid energy + metabolism
In comparison, injectable BPC-157 enters the bodys tissues through a syringe and needle
US$ 23.13
US$ 21.85
US$ 24.55
US$ 25.47
US$ 28.12
US$ 21.12
US$ 25.38
US$ 26.36
US$ 28.26
US$ 25.76
US$ 21.42
US$ 25.67
US$ 27.72
US$ 21.17
US$ 26.36
US$ 22.34
